Glenmark Pharma shares up 2% after FDA grants fast track status to cancer drug
Glenmark Prescription drugs shares climbed as a lot as 1.8% on Tuesday to Rs 1,431.25 on the BSE after the ...
Wednesday, June 4, 2025
Tag: FDA
NeuroSense schedules FDA meeting for ALS drug trial By Investing.com
CAMBRIDGE, Mass. - NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a biotech agency specializing in neurodegenerative illness therapies, has secured a Kind ...
Biogen’s kidney transplant rejection candidate gets FDA breakthrough designation
peterschreiber.media Biogen (NASDAQ:BIIB) has obtained U.S. FDA breakthrough remedy designation for felzartamab, its candidate being developed to deal with antibody-mediated ...
Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Supply: Recursion Prescribed drugsAI drug pioneer Recursion Prescribed drugs stated Wednesday that one in all its experimental remedies hit a ...
RECOMMENDED
Why India’s hotels enjoy highest EV per room globally
India’s lodge sector is hogging the headlines with the nation witnessing its largest-ever hospitality IPO. Brookfield-backed Schloss Bangalore, proprietor of...
Copyright © 2024 PWC.